
Genetic engineering
Check carefully, approve safely.
The release of genetically modified organisms (GMO) for scientific trials needs to be approved by the BVL. If GMO are to be cultivated commercially, the BVL will provide a statement in the Community approval process of the EU. Furthermore, the BVL manages the international information exchange on GMO in the Biosafety Clearing House for Germany. The BVL hosts the secretary of the Central Committee on Biological Safety (ZKBS). The ZKBS advises the Federal Government and the Federal States in safety-relevant questions on genetic engineering.
Many topics, one goal

Deliberate release
Here you will find information on the procedure, application and authorisation of a deliberate release of GMOs.

Placing on the market
Here you will find information on the procedure, application and authorisation of the placing on the market of GMOs.

Transport of genetically modified organisms
Basic requirements for the transport of GMOs and their import and export are explained here in more detail.

Genetically modified organisms after authorisation
After completing the authorisation procedure for placing on the market, GMOs are subject to specific regulations, which are explained here (e.g. labelling or entry into the GMO location register).

Responsibilities for biosafety institutions
Here you will find information on the Central Committee on Biological Safety (ZKBS) and the Cartagena Protocol.

Detection methods and sampling
The competent laboratories of the Federal States analyse samples for GMO content on a regular basis.

More information
Here you will find databases and links which are available in the field of genetic engineering.

Legal framework
Here you will find an overview of the legal framework at national, European and international level.
Find out more
- Tasks in the area of genetic engineering
- For consumers
- For applicants and practitioners